219 related articles for article (PubMed ID: 18979164)
21. Diagnosis and treatment of Paget's disease of bone: a mini-review.
Ferraz-de-Souza B; Correa PH
Arq Bras Endocrinol Metabol; 2013 Nov; 57(8):577-82. PubMed ID: 24343625
[TBL] [Abstract][Full Text] [Related]
22. Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.
Polyzos SA; Anastasilakis AD; Efstathiadou Z; Litsas I; Kita M; Panagiotou A; Papatheodorou A; Arsos G; Moralidis E; Barmpalios G; Zafeiriadou E; Triantafillidou E; Makrigiannaki E; Terpos E
J Bone Miner Metab; 2010 May; 28(3):314-9. PubMed ID: 19841860
[TBL] [Abstract][Full Text] [Related]
23. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
24. The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone.
Polyzos SA; Anastasilakis AD; Efstathiadou Z; Kita M; Litsas I; Avramidis A; Arsos G; Moralidis E; Gerou S; Pavlidou V; Papatheodorou A; Terpos E
Horm Metab Res; 2009 Nov; 41(11):846-50. PubMed ID: 19670154
[TBL] [Abstract][Full Text] [Related]
25. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
Conesa Mateos A; Rotés Sala D; Almirall Bernabé M; Carbonell Abelló J
Med Clin (Barc); 2006 Oct; 127(16):635-6. PubMed ID: 17145033
[No Abstract] [Full Text] [Related]
26. Long-Term Efficacy of Intensive Zoledronate Therapy and Predictors of Retreatment in Paget's Disease of Bone.
Barale M; Sigrist S; Bioletto F; Maiorino F; Ghigo E; Mazzetti R; Procopio M
Calcif Tissue Int; 2021 Oct; 109(4):383-392. PubMed ID: 33876253
[TBL] [Abstract][Full Text] [Related]
27. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Krane SM
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
[No Abstract] [Full Text] [Related]
28. Active Paget's disease of bone with normal biomarkers of bone metabolism: a case report and review of the literature.
Gkouva L; Andrikoula M; Kontogeorgakos V; Papachristou DJ; Tsatsoulis A
Clin Rheumatol; 2011 Jan; 30(1):139-44. PubMed ID: 20886248
[TBL] [Abstract][Full Text] [Related]
29. Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.
Polyzos SA; Kountouras J; Anastasilakis AD; Litsas I; Kita M; Arsos G; Moralidis E; Terpos E
Osteoporos Int; 2011 Jan; 22(1):363-7. PubMed ID: 20407889
[TBL] [Abstract][Full Text] [Related]
30. Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent
Cronin O; Forsyth L; Goodman K; Lewis SC; Keerie C; Walker A; Porteous M; Cetnarskyj R; Ranganath LR; Selby PL; Hampson G; Chandra R; Ho S; Tobias JH; Young-Min S; McKenna MJ; Crowley RK; Fraser WD; Gennari L; Nuti R; Brandi ML; Del Pino-Montes J; Devogelaer JP; Durnez A; Isaia G; Di Stefano M; Guañabens N; Blanch J; Seibel MJ; Walsh JP; Kotowicz MA; Nicholson GC; Duncan EL; Major G; Horne A; Gilchrist NL; Boers M; Murray GD; Charnock K; Wilkinson D; Russell RGG; Ralston SH
BMJ Open; 2019 Sep; 9(9):e030689. PubMed ID: 31488492
[TBL] [Abstract][Full Text] [Related]
31. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
[TBL] [Abstract][Full Text] [Related]
32. (18)F-fluoride PET for monitoring therapeutic response in Paget's disease of bone.
Installé J; Nzeusseu A; Bol A; Depresseux G; Devogelaer JP; Lonneux M
J Nucl Med; 2005 Oct; 46(10):1650-8. PubMed ID: 16204715
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
Muschitz C; Feichtinger X; Haschka J; Kocijan R
Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
[TBL] [Abstract][Full Text] [Related]
34. Proposed new approach for treating Paget's disease of bone.
Mahmood W; McKenna MJ
Ir J Med Sci; 2011 Mar; 180(1):121-4. PubMed ID: 21132539
[TBL] [Abstract][Full Text] [Related]
35. [Paget's disease of bone: diagnosis and treatment].
Winter EM; Hamdy NA; de Jongh RT; Eekhoff EM; Zillikens MC; Appelman-Dijkstra NM
Ned Tijdschr Geneeskd; 2016; 160():D254. PubMed ID: 27650015
[TBL] [Abstract][Full Text] [Related]
36. Zoledronic acid for treatment of Paget's disease of bone.
Devogelaer JP; Manicourt DH
Expert Opin Pharmacother; 2007 Nov; 8(16):2863-9. PubMed ID: 17956205
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of Paget's disease of bone: importance of the zoledronic acid].
Griz L; Colares V; Bandeira F
Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):845-51. PubMed ID: 17160207
[TBL] [Abstract][Full Text] [Related]
38. Paget's disease of bone: analysis of 134 cases from an island in Southern Brazil: another cluster of Paget's disease of bone in South America.
Werner de Castro GR; Heiden GI; Zimmermann AF; Morato EF; Neves FS; Toscano MA; de Magalhães Souza Fialho SC; Pereira IA
Rheumatol Int; 2012 Mar; 32(3):627-31. PubMed ID: 21127877
[TBL] [Abstract][Full Text] [Related]
39. The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.
Gennari L; Merlotti D; Mossetti G; Rendina D; De Paola V; Martini G; Nuti R
Mini Rev Med Chem; 2009 Aug; 9(9):1052-63. PubMed ID: 19689402
[TBL] [Abstract][Full Text] [Related]
40. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
Whitson HE; Lobaugh B; Lyles KW
Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
